Unified protocol for anxiety disorders in two cities of Mexico measuring gamma activity: Study protocol for a randomized controlled trial.

Anxiety disorders Electroencephalography Mexican population Randomized controlled trial Unified protocol

Journal

Contemporary clinical trials communications
ISSN: 2451-8654
Titre abrégé: Contemp Clin Trials Commun
Pays: Netherlands
ID NLM: 101671157

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 08 12 2019
revised: 02 03 2020
accepted: 14 03 2020
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 11 4 2020
Statut: epublish

Résumé

The Unified Protocol for Emotional Disorders (UP) for emotional regulation manifests effective results in a broad range of mental disorders. The UP efficacy was tested in several countries, but it has not been tested within Mexican population. It is crucial to do more research and implement effective protocols to intervene Mexican population with Anxiety Disorders (AD). This study aims to examine and describe the research procedures and treatment interventions of the UP in a Randomized Controlled Trial (RCT), to approach and treat AD in patients in 2 Mexican borderland cities, by applying the UP and an Electroencephalogram (EGG) neuro screening. The enrolled patients will be randomized in a two-arm control trial with repeated measures, comprising between 18 and 60 years, that were diagnosed with an AD, and low scored in depression symptoms and suicidal ideation. The study will comprise of two conditions: an intervention group clinical trial with the UP or a waiting list control. The primary outcome measures will be applied on AD quantitative self-reports and a gamma activity by EGG before and after the intervention and in follow-ups of 3 and 6 months. The participants in the waiting list group, will receive the treatment after the trial first group completes the treatment. Processes and outcomes of this project, will provide evidence in order to apply the UP in a broader population with AD and other mental disorders also covered by this protocol, such as depression and borderline personality disorder in a broader Mexican population, a country that suffers with a major health issue with an increasing rate of mental disorders and scarce psychological and health coverage.

Sections du résumé

BACKGROUND BACKGROUND
The Unified Protocol for Emotional Disorders (UP) for emotional regulation manifests effective results in a broad range of mental disorders. The UP efficacy was tested in several countries, but it has not been tested within Mexican population. It is crucial to do more research and implement effective protocols to intervene Mexican population with Anxiety Disorders (AD).
OBJECTIVE OBJECTIVE
This study aims to examine and describe the research procedures and treatment interventions of the UP in a Randomized Controlled Trial (RCT), to approach and treat AD in patients in 2 Mexican borderland cities, by applying the UP and an Electroencephalogram (EGG) neuro screening.
METHODS METHODS
The enrolled patients will be randomized in a two-arm control trial with repeated measures, comprising between 18 and 60 years, that were diagnosed with an AD, and low scored in depression symptoms and suicidal ideation. The study will comprise of two conditions: an intervention group clinical trial with the UP or a waiting list control. The primary outcome measures will be applied on AD quantitative self-reports and a gamma activity by EGG before and after the intervention and in follow-ups of 3 and 6 months. The participants in the waiting list group, will receive the treatment after the trial first group completes the treatment.
CONCLUSIONS CONCLUSIONS
Processes and outcomes of this project, will provide evidence in order to apply the UP in a broader population with AD and other mental disorders also covered by this protocol, such as depression and borderline personality disorder in a broader Mexican population, a country that suffers with a major health issue with an increasing rate of mental disorders and scarce psychological and health coverage.

Identifiants

DOI: 10.1016/j.conctc.2020.100556 PMID: 32274440 PMC: PMC7136174
pubmed: 32274440
doi: 10.1016/j.conctc.2020.100556
pii: S2451-8654(20)30040-5
pii: 100556
pmc: PMC7136174
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100556

Informations de copyright

© 2020 The Authors. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Authors have no competing interests to declare.

Références

An Sist Sanit Navar. 2009;32 Suppl 3:69-82
pubmed: 20094087
Psychol Assess. 2001 Sep;13(3):347-55
pubmed: 11556271
Trials. 2015 Oct 31;16:488
pubmed: 26519046
Behav Ther. 2012 Sep;43(3):666-78
pubmed: 22697453
J Pers Assess. 1984 Feb;48(1):95-7
pubmed: 6707862
J Pers Assess. 1996 Dec;67(3):588-97
pubmed: 8991972
Traumatology (Tallahass Fla). 2014 Mar 1;20(1):24-31
pubmed: 25110466
J Affect Disord. 2015 Feb 1;172:179-83
pubmed: 25451415
J Clin Psychol. 1988 Jul;44(4):499-505
pubmed: 3170753
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Hum Reprod Sci. 2011 Jan;4(1):8-11
pubmed: 21772732
Int J Endocrinol Metab. 2012 Spring;10(2):486-9
pubmed: 23843808
Psychol Assess. 2003 Dec;15(4):569-77
pubmed: 14692850
Biol Psychol. 2008 Oct;79(2):165-70
pubmed: 18499328
J Pers Disord. 2016 Feb;30(1):35-51
pubmed: 25710737
Psychiatr Serv. 2017 May 1;68(5):497-502
pubmed: 27974004
Int J Psychophysiol. 2012 Apr;84(1):65-73
pubmed: 22280842
J Affect Disord. 2016 Nov 01;204:124-30
pubmed: 27344621
JAMA Psychiatry. 2017 Sep 1;74(9):875-884
pubmed: 28768327
Cyberpsychol Behav. 2007 Oct;10(5):722-4
pubmed: 17927544
Biol Psychol. 2011 Jul;87(3):379-85
pubmed: 21571033
PLoS One. 2015 Apr 13;10(4):e0122969
pubmed: 25874558
PLoS One. 2018 Nov 1;13(11):e0206516
pubmed: 30383797
Trends Psychiatry Psychother. 2013;35(2):134-40
pubmed: 25923304
Clin Psychol Rev. 2019 Aug;72:101751
pubmed: 31271848
Cogn Behav Pract. 2010 Feb;17(1):88-101
pubmed: 33762811
Depress Anxiety. 2006;23(4):245-9
pubmed: 16688739
Health Qual Life Outcomes. 2010 Jan 20;8:8
pubmed: 20089179
Clin Psychol Rev. 2006 Jan;26(1):17-31
pubmed: 16199119
Emotion. 2008 Aug;8(4):560-72
pubmed: 18729586
Soc Sci Med. 2018 Aug;210:2-21
pubmed: 29331519
Psychometrika. 2010 Jun;75(2):243-248
pubmed: 20640194

Auteurs

A Dominguez-Rodriguez (A)

Faculty of Medicine and Psychology, Autonomous University of Baja California, Calzada Universidad 14418, Parque Industrial Internacional Tijuana, Tijuana, B.C, 22427, Mexico.

S M Chavez-Valdez (SM)

Faculty of Psychology, Escuela Libre de Psicología, A.C. ELPAC-Universidad de Ciencias del Comportamiento, ELPAC University of Behavioral Sciences, Calle Pedro Zuloaga #8805, Colonia Labor de Terrazas, Chihuahua, Chih, 31207, Mexico.

G C Avitia (GC)

Institute of Social Sciences and Administration, Autonomous University of Ciudad Juárez, Av. Universidad y Av. Heroico Colegio Militar Zona Chamizal, 32300, Juarez, Chihuahua, Mexico.

L C Valencia-Espinoza (LC)

Faculty of Medicine and Psychology, Autonomous University of Baja California, Calzada Universidad 14418, Parque Industrial Internacional Tijuana, Tijuana, B.C, 22427, Mexico.

Classifications MeSH